Thalidomide

• Description:

  Thalidomide can directly inhibit angiogenesis induced by bFGF or VEGF in vivo.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  258.23

• Molecular Formula:

  C13H10N2O4

• Notes:

  Research use only, not for human use.

• Receptor:

  TNF-α

• CAS Number:

  50-35-1